Researchers at Boston Children’s Hospital have created an imaging technology called BCR-MERFISH that shows where different groups of antibody-producing cells are located in tissue. Reported in Nature Methods, the approach may help researchers learn how immune responses contribute to disease. It could eventually inform new diagnosis and treatment strategies for inflammatory bowel disease, autoimmune disorders, infections, and cancer. “This work allows us to see the aspects of spatial organization of the adaptive immune system in tissues that we could never see before,” said senior author Jeffrey R. Moffitt.
Plasma cells make antibodies, the proteins the body uses to recognize and fight threats. Two of them can look almost the same under a microscope while producing antibodies aimed at very different targets. Earlier imaging methods could label cell types and states, but they could not easily tell these plasma cells apart.
BCR-MERFISH extends MERFISH, or multiplexed error-robust fluorescence in situ hybridization, a microscopy method that measures RNA to show which genes cells are using. First author Evan Yang modified it so that it sorts plasma cells into groups according to selected antibody receptor gene features. It also records gene activity in neighboring cells. “People have started to put this information in space, but BCR-MERFISH increases the resolution we have dramatically,” Moffitt said.
Search Antibodies Search Now Use our Antibody Search Tool to find the right antibody for your research. Filter
by Type, Application, Reactivity, Host, Clonality, Conjugate/Tag, and Isotype.
To test the method, the team examined mouse small intestine. Across two extended tissue sections, they imaged over 300,000 cells and sorted plasma cells into 434 groups based on which antibody receptor genes they used. The resulting maps showed that certain groups gathered in clusters along the intestine instead of spreading evenly. “We did not expect to see these clusters at all,” Moffitt said. He added that the cause of the clusters, and their significance for immune function, are not yet known.
The researchers also compared mice carrying typical gut microbes with germ-free mice raised without microorganisms. The germ-free animals, as anticipated, had fewer plasma cells and a less varied set of identifiable groups.
Linking a cell’s identity to its exact position could clarify how antibody-producing cells act where inflammation and disease occur. In Crohn’s disease and ulcerative colitis, for instance, tissue architecture shifts and plasma cells collect at affected sites, yet scientists have had little ability to separate groups of these cells or study how they relate to nearby cells. The method might also support work on tumors, B-cell lymphomas, and other conditions involving the adaptive immune system.